Australia's most trusted
source of pharma news
Wednesday, 06 May 2026
Posted 6 May 2026 AM
Australian agentic AI commercialisation company RoseRx has announced its expansion to the US, opening an office in Boston to meet growing demand for its platform from global pharmas.
The company which specialises in the pharma and life sciences space has been working with US customers from its Sydney base since late 2025 with its business growing rapidly in the first three months of 2026.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.